Technical Data: Examination of the Membrane Filter Method using Microbio μ3D
Study of Membrane Filtration Method Using MB04 Filter
This technical document presents the results of the verification of the microbial count measurement time using the "MB04 filter" with the Microbio μ3D Auto Scanner. The "Microbio μ3D Auto Scanner" is a system that continuously monitors the growth of bacteria using the mixed plate method, plate spread method, and membrane filter method. While based on the culture methods used in official or standard microbial count tests, it allows for measurement of the number of bacteria in and on the medium much more quickly and accurately compared to visual counting. 【Overview】 ■ Purpose ■ Materials and Methods ■ Measurement Results ■ Discussion ■ Conclusion ■ Introduction to the Microbio μ3D Auto Scanner *For more details, please refer to the catalog or feel free to contact us.
Inquire About This Product
basic information
【Publication Content】 ■Objective ・Verification of the measurement time for viable bacterial counts using the MB04 filter with the Microbio μ3D Auto Scanner ■Materials and Methods ・Test strains ・Sample preparation and testing conditions ・Verification of the start time for colony detection and the final bacterial count detection time ■Measurement Results ■Discussion ■Conclusion ■Introduction to the Microbio μ3D Auto Scanner *For more details, please refer to the catalog or feel free to contact us.
Price information
Please contact us.
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.